# Goal Setting to Promote Physical Activity Adherence in Midlife to Reduce Risk of Alzheimer's Disease and Related-Dementias: A Randomized Mechanistic Proof-of-Concept Trial

> **NIH NIH R61** · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · 2023 · $190,598

## Abstract

Project Summary
More than 6 million U.S. adults live with diagnoses of Alzheimer's Disease and Related Dementias
(AD/ADRD), with projections as high as 13.8 million cases by 2050. There are no cures for AD/ADRD, making
lifestyle factors key targets for reducing risk, as they account for at least a third of AD/ADRD cases. Engaging in
regular physical activity (PA), particularly in midlife, is associated with reduced risk for AD/ADRD. Yet nearly
half of midlife adults (48%) do not meet national PA guidelines of 150 minutes/week of moderate-intensity PA.
Goal setting is a commonly used behavior change strategy to increase PA. Key psychosocial mechanisms
believed to underpin the use of goal setting to promote PA include self-regulation and self-efficacy. Yet, the
most effective goal setting technique to enhance these psychosocial mechanisms for the successful promotion
of PA and adherence to national PA guidelines remains unclear. In the proposed study, we will use a two-
phased approach to empirically test three goal setting techniques to enhance psychosocial mechanisms of self-
regulation and self-efficacy for the successful promotion of PA and adherence to national PA guidelines among
insufficiently active midlife adults with obesity. In the R61 phase, a Phase 1 pilot study will establish feasibility
and help refine the intervention. In the R33 phase, a Phase 2 9-month 4-arm proof-of-concept mechanistic trial
(6-month active intervention and 3-month no contact follow-up) will be implemented to establish preliminary
efficacy of goal setting techniques to increase PA and promote adherence to national PA guidelines. All
participants will receive a Fitbit to self-monitor PA and engage in PA action planning sessions with a study
interventionist. In addition, participants will be randomly assigned to 1 of 4 groups: i) static weekly goal of 150
minutes/week of moderate-intensity PA, which most closely resembles the approach of public health
campaigns and care providers; ii) weekly self-selected PA goals, which allows for self-determination and
adaptation of the goal; iii) modest incremental weekly PA increase goal (i.e., researcher determined PA goal
that 20% minutes/week greater than the minutes/week of PA in the previous week); or iv) non-goal setting
control group. Based on Goal Setting Theory, it is hypothesized that participants in the incremental goal group
will have the greatest increases in self-regulation and self-efficacy, which in turn, will lead to the greatest
improvements in PA and adherence to national PA guidelines over the 9-month intervention. Further,
individuals with the greatest PA adherence are expected to experience the greatest improvements in AD/ADRD
risk factors, including cognitive functioning (memory, executive functioning, processing speed), AD plasma
biomarkers (plasma amyloid 42/40 ratio. plasma phosphorylated tau 231), and measures of cardiometabolic
disease risk (BMI, blood pressure, plasma glucose, TG, total cholesterol,...

## Key facts

- **NIH application ID:** 10696085
- **Project number:** 5R61AG078089-02
- **Recipient organization:** ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
- **Principal Investigator:** Rodney Joseph
- **Activity code:** R61 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $190,598
- **Award type:** 5
- **Project period:** 2022-09-15 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10696085

## Citation

> US National Institutes of Health, RePORTER application 10696085, Goal Setting to Promote Physical Activity Adherence in Midlife to Reduce Risk of Alzheimer's Disease and Related-Dementias: A Randomized Mechanistic Proof-of-Concept Trial (5R61AG078089-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10696085. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*